Table of Contents
Volume 4 | Issue 2
Publication Date: September 2002- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
75 |
Impact of INTACT: Do We Change the Target or the Aim? Sakkaraiappan Ramalingam, Chandra P. Belani |
|
Researches in Brief | ||
76-79 |
Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer: Data from Randomized Phase III Trials Amy D’Orazio, Chandra P. Belani |
|
80-82 |
Cell-Cycle Inhibitors as Novel Therapies for Lung Cancer Heather DeGrendele, Chandra P. Belani, Geoffrey Shapiro, Michael C. Perry |
|
Comprehensive Review | ||
87-94 |
Small-Cell Lung Cancer: State of the Art Nasser H. Hanna, Lawrence H. Einhorn |
|
Original Contributions | ||
95-103 |
Radiotherapy Versus Chemotherapy Plus Radiotherapy in Surgically Treated IIIA N2 Non–Small-Cell Lung Cancer Anthony D. Elias, Parvesh Kumar, James Herndon III, Arthur T. Skarin, David J. Sugarbaker, Mark R. Green, for the Cancer and Leukemia Group B |
|
104-109 |
Real-Time Clinical Application of Quality-of-Life Assessment in Advanced Lung Cancer Chih-Hung Chang, David Cella, Gregory A. Masters, Nicole Laliberte, Paul O’Brien, Amy Peterman, Daniel Shevrin |
|
Commentary | ||
110 |
The Importance of Quality-of-Life Measurements in Oncology J. Lee Villano, Marcy A. List, Everett E. Vokes |
|
Translational Medicine | ||
111-123 |
Promising Developments in Targeted Therapies for Non–Small-Cell Lung Cancer Desirée Hao, Manuel Hidalgo |
|
Commentary | ||
124 |
“Targeted” Therapies for Non–Small-Cell Lung Cancer Alex A. Adjei |
|